Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

FromInvestors' Chronicle


The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

FromInvestors' Chronicle

ratings:
Length:
39 minutes
Released:
Jul 15, 2022
Format:
Podcast episode

Description

On this week's show, we get the breakdown on GSK spinoff Haleon which is set to list next week.Then Arthur Sants takes a fascinating dive into the business of psychedelic drugs, and whether they can be the future of depression and anxiety treatment.Finally, the panel look into the potential European gas crisis, with the threat of Russian pipelines being turned off hanging over the continent.Dan Jones host Alex Newman, Alex Hamer, Mark Robinson and Arthur Sants.Timestamps:00:00 - Intro01:00 - News roundup02:49 - GSK spinoff Haleon listing previewed13:24 - Can psychedelics be the future of anxiety treatment?23:16 - A looming European gas crisis? Hosted on Acast. See acast.com/privacy for more information.
Released:
Jul 15, 2022
Format:
Podcast episode

Titles in the series (100)

Concerned with QE's effects on equity valuations? Looking for ideas for your Isa? Or just plain confused by the stock market? Each week, the Investors Chronicle picks apart the latest news for companies, markets and funds in our regular magazine podcasts. Subscribe for these, along with CEO interviews, company-specific shows and special in-depth discussions on big market themes. Hosted on Acast. See acast.com/privacy for more information.